Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing);
Department of Gastrointestinal Oncology;
Peking University Cancer Hospital&Institute;
Beijing 100142;
China;
Health Science Center;
Peking University;
Beijing 100191;
China;
Claudin 18.2; gastric cancer; zolbetuximab; chimeric antigen receptor therapy;